Loading, please wait ...

News Analytics

Sanofi jpg?VersionId=VCfXV5IPYjl1wkdtuxFKKigB6U scvVp.
Sanofi’s $3.7 billion acquisition of Principia Biopharma has been taking barbs from all sides, so perhaps some long-term follow-up data on the multiple sclerosis candidate at the heart of the deal will quiet the criticism. The French pharma showcased 48-week results for a phase 2b trial of tolebrutinib at the 37th Congress of the European Committee for Treatment and Research ...

The Angle

Subject Matter

  • Healthcare 53.13%
    • Hospitals, doctors and medical care 100.00%
  • Science and technology 46.88%

Emotional Reaction






Dimensions/Depth Chart

If you find a dimension intereseting, we recommend you pick up one or two facts that you find intriguing and place them into your memory. That way you will have 2nd degree information about the topic if it comes up in conversation.

Accordingly, you can do the same with others as well.